Integration of digital fluoroscopy with CT-based radiation therapy planning of lung tumors.
暂无分享,去创建一个
[1] Isaias D. Job,et al. Characterization of a third-generation multimode sensor panel , 1999, Medical Imaging.
[2] A R Cowen,et al. Threshold contrast detail detectability measurement of the fluoroscopic image quality of a dynamic solid-state digital x-ray image detector. , 2001, Medical physics.
[3] J. Ciezki,et al. Fluoroscopic study of tumor motion due to breathing: facilitating precise radiation therapy for lung cancer patients. , 2001, Medical physics.
[4] R. Jaszczak,et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. , 2001, International journal of radiation oncology, biology, physics.
[5] J C Rosenwald,et al. Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing. , 2001, International journal of radiation oncology, biology, physics.
[6] S Senan,et al. Multiple "slow" CT scans for incorporating lung tumor mobility in radiotherapy planning. , 2001, International journal of radiation oncology, biology, physics.
[7] W. Stanford,et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. , 1990, International journal of radiation oncology, biology, physics.
[8] D. Joseph,et al. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] R Mackie,et al. A new approach to dose escalation in non-small-cell lung cancer. , 2001, International journal of radiation oncology, biology, physics.
[10] S. Korfee,et al. Lung cancer: Combined modality therapy in NSCLC , 2000 .
[11] James A. Purdy,et al. 3-D Conformal Radiotherapy for Lung Cancer , 1996 .
[12] J. Purdy,et al. Three-dimensional conformal radiotherapy in bronchogenic carcinoma: considerations for implementation. , 1994, Lung cancer.
[13] R K Ten Haken,et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] A Harvey,et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] M. Martel,et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.
[17] H Shirato,et al. Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[18] H. Choy,et al. Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial. , 2001, Lung cancer.
[19] M. Kris,et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] K. Lam,et al. Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. , 1996, International journal of radiation oncology, biology, physics.
[21] B. Freidlin,et al. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Doroshow,et al. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.